Abstract

To enhance the understanding of artemisinin biosynthesis, we have successfully bred self-pollination Artemisia annua plants. Here, we report efficient somatic embryogenesis and organogenesis of self-pollination plants and artemisinin formation in regenerated plants. The first through sixth nodal leaves of seedlings are used as explants. On agar-solidified MS basal medium supplemented with TDZ (0.6 mg/l) and IBA (0.1 mg/l), all explants after inoculation of less than 3 weeks start to form embryogenic calli, which further produce globular, torpedo, heart and early cotyledon embryos. In all six positional leaves, explants from the sixth leaf show the rapidest responses to induction of embryogenic calli and somatic embryos. On this medium, somatic embryos continuously develop into adventitious buds, which can form adventitious roots on a rooting medium containing NAA (0.5 mg/l). Meanwhile, on agar-solidified MS basal medium supplemented with BAP (1 mg/l) and NAA (0.05 mg/l), approximately 100% of explants from leaves #3-6 form calli in less than 3 weeks of inoculation and adventitious buds via organogenesis in 3-4 weeks. In all six positional leaves, explants from the sixth leaf exhibit the rapidest response to induction of calli and adventitious buds. Nearly 100% adventitious buds can form adventitious roots on the rooting medium. Regenerated plants from both somatic embryogenesis and organogenesis complete self-pollination to produce seeds in 80-90 days of growth in growth chamber. LC-ESI-MS analysis demonstrates that regenerated plants biosynthesize artemisinin. These results show the highly efficient regeneration capacity of self-pollination A. annua plants that can form a new platform to enhance the understanding of artemisinin biosynthesis and metabolic engineering.

Highlights

  • Artemisia annua is the only natural resource producing artemisinin which is the main compound used in the artemisinin-based combination therapy (ACT) fighting against malarial diseases caused by parasites, such as Plasmodium falciparum and P. viva [1,2,3,4,5]

  • The high regeneration variation of different ecotypes of A. annua plants has been reported to be a severe hurdle for the success of genetic transformation

  • Our experiments demonstrate a high and reproducible regeneration efficiency of selfpollinated A. annua progeny through both somatic embryogenesis and organogenesis

Read more

Summary

Introduction

Artemisia annua is the only natural resource producing artemisinin which is the main compound used in the artemisinin-based combination therapy (ACT) fighting against malarial diseases caused by parasites, such as Plasmodium falciparum and P. viva [1,2,3,4,5]. Malaria is one of the most severe infectious diseases causing life loss of approximately one million people every year. Since 1970s when artemisinin was identified to be an endoperoxide lactone sesquiterpene in A. annua by Chinese scientists [6,7], its medicinal activity helped Chinese people to effectively fight against and control malarial disease in China. Later on, this medicine was recommended to other epidemic countries and regions by World Health Organization (WHO) [1,3,8]. The biochemical and transgenic elucidation of biosynthetic steps from amorpha-4, Open Access

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call